Culture

Landmark study details sequencing of 64 full human genomes to better capture genetic diversity

image: Structure of Genome

Image: 
NIH

Researchers at the University of Maryland School of Medicine (UMSOM) co-authored a study, published today in the journal Science, that details the sequencing of 64 full human genomes. This reference data includes individuals from around the world and better captures the genetic diversity of the human species. Among other applications, the work will enable population-specific studies on genetic predispositions to human diseases as well as the discovery of more complex forms of genetic variation.

Twenty years ago this month, the International Human Genome Sequencing Consortium announced the first draft of the human genome reference sequence. The Human Genome Project, as it was called, required 11 years of work and involved more than 1000 scientists from 40 countries. This reference, however, did not represent a single individual, but instead was a composite of humans that could not accurately capture the complexity of human genetic variation.

Building on this, scientists have conducted several sequencing projects over the last 20 years to identify and catalog genetic differences between an individual and the reference genome. Those differences usually focused on small single base changes and missed larger genetic alterations. Current technologies now are beginning to detect and characterize larger differences - called structural variants - such as insertions of new genetic material. Structural variants are more likely than smaller genetic differences to interfere with gene function.

The new finding in Science announced a new and significantly more comprehensive reference dataset that was obtained using a combination of advanced sequencing and mapping technologies. The new reference dataset reflects 64 assembled human genomes, representing 25 different human populations from across the globe. Importantly, each of the genomes was assembled without guidance from the first human genome composite. As a result, the new dataset better captures genetic differences from different human populations.

"We've entered a new era in genomics where whole human genomes can be sequenced with exciting new technologies that provide more substantial and accurate reads of the DNA bases," said study co-author Scott Devine, PhD, Associate Professor of Medicine at UMSOM and faculty member of IGS. "This is allowing researchers to study areas of the genome that previously were not accessible but are relevant to human traits and diseases."

Institute of Genome Science (IGS)'s Genome Resource Center (GRC) was one of three sequencing centers, along with Jackson Labs and the University of Washington, that generated the data using a new sequencing technology that was developed recently by Pacific Biosciences. The GRC was one of only five early access centers that was asked to test the new platform.

Dr. Devine helped to lead the sequencing efforts for this study and also led the sub-group of authors who discovered the presence of "mobile elements" (i.e., pieces of DNA that can move around and get inserted into other areas of the genome). Other members of the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine are among the 65 co-authors. Luke Tallon, PhD, Scientific Director of the Genomic Resource Center, worked with Dr. Devine to generate one of the first human genome sequences on the Pacific Bioscences platform that was contributed to this study. Nelson Chuang, a graduate student in Dr. Devine's lab also contributed to the project.

"The landmark new research demonstrates a giant step forward in our understanding of the underpinnings of genetically-driven health conditions," said E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of Medicine. "This advance will hopefully fuel future studies aimed at understanding the impact of human genome variation on human diseases."

Credit: 
University of Maryland School of Medicine

What might sheep and driverless cars have in common? Following the herd

Psychologists have long found that people behave differently than when they learn of peers' actions. A new study by computer scientists found that when individuals in an experiment about autonomous vehicles were informed that their peers were more likely to sacrifice their own safety to program their vehicle to hit a wall rather than hit pedestrians who were at risk, the percentage of individuals willing to sacrifice their own safety increased by approximately two-thirds.

As computer scientists train machines to act as people's agents in all sorts of situations, the study's authors indicate that the social component of decision-making is often overlooked. This could be of great consequence, note the paper's authors who show that the trolly problem -long shown to be the scenario moral psychologists turn to--is problematic. The problem, the authors indicate, fails to show the complexity of how humans make decisions.

Jonathan Gratch, one of the paper's author, the principal investigator for this project, and a computer scientist at the USC Institute for Creative Technologies, says existing models assume that in high stakes life and death decisions, people think differently than they actually do. He indicates that there are not moral absolutes for human decision-making but rather "it is more nuanced," says Gratch.

The researchers conducted four separate simulation experiments to understand how people might process and act on the moral dilemmas they would face as an operator of a driverless car. The first three experiments focused on human behavior when faced with risk to themselves and others in the event of negative scenario in which the vehicle would have to be programmed to either the car to hit the wall or hit five pedestrians. The authors prove that participants would use severity of injury to self and the risk to others as guideposts for decision-making. They found that the higher the risk to pedestrians; the more likely people were likely to self -sacrifice their own health. In addition, the level of risk to pedestrians did not to have to be as high as for the operator of the autonomous vehicle to sacrifice their own well-being.

In the fourth experiment, the researchers added a social dimension telling participants what peers had opted to do in the same situation. In one simulation, the knowledge that peers chose to risk their own health changed the participants' responses, rising from 30 percent who were willing to risk their health to 50 percent. But this can go both ways cautions Gratch. "Technically there are two forces at work. When people realize their peers don't care, this pulls people down to selfishness. When they realize they care, this pulls them up."

The research has implications for autonomous vehicles including drones and boats, as well as robots that are programmed by humans. The authors suggest that it is important for manufacturers to have an awareness of how humans actually make decisions in life or death situations. In addition, the authors imply that transparency in how machines are programmed as well as relinquishing controls to the human drivers so that they might change settings prior to these life and death situations are important for the public. They also suggest it is important for legislators to be aware of how vehicles might be programmed. Lastly, given the human susceptibility to conform to social norms, the authors believe that public health campaigns related to how peers programmed their autonomous vehicles for self-sacrifice might influence future owners to change their vehicle settings to be more oriented to protecting others from injury and choose self-sacrifice.

Credit: 
University of Southern California

First complete coronavirus model shows cooperation

video: Coarse-grained molecular dynamics simulation of the SARS-CoV-2 virion using LAMMPS for 10 × 106 CG time steps.

Image: 
Gregory Voth, University of Chicago.

The COVID-19 virus holds some mysteries. Scientists remain in the dark on aspects of how it fuses and enters the host cell; how it assembles itself; and how it buds off the host cell.

Computational modeling combined with experimental data provides insights into these behaviors. But modeling over meaningful timescales of the pandemic-causing SARS-CoV-2 virus has so far been limited to just its pieces like the spike protein, a target for the current round of vaccines.

A new multiscale coarse-grained model of the complete SARS-CoV-2 virion, its core genetic material and virion shell, has been developed for the first time using supercomputers. The model offers scientists the potential for new ways to exploit the virus's vulnerabilities.

"We wanted to understand how SARS-CoV-2 works holistically as a whole particle," said Gregory Voth, the Haig P. Papazian Distinguished Service Professor at the University of Chicago. Voth is the corresponding author of the study that developed the first whole virus model, published November 2020 in the Biophysical Journal.

"We developed a bottom-up coarse-grained model," said Voth, "where we took information from atomistic-level molecular dynamics simulations and from experiments." He explained that a coarse-grained model resolves only groups of atoms, versus all-atom simulations, where every single atomic interaction is resolved. "If you do that well, which is always a challenge, you maintain the physics in the model."

The early results of the study show how the spike proteins on the surface of the virus move cooperatively.

"They don't move independently like a bunch of random, uncorrelated motions," Voth said. "They work together."

This cooperative motion of the spike proteins is informative of how the coronavirus explores and detects the ACE2 receptors of a potential host cell.

"The paper we published shows the beginnings of how the modes of motion in the spike proteins are correlated," Voth said. He added that the spikes are coupled to each other. When one protein moves another one also moves in response.

"The ultimate goal of the model would be, as a first step, to study the initial virion attractions and interactions with ACE2 receptors on cells and to understand the origins of that attraction and how those proteins work together to go on to the virus fusion process," Voth said.

Voth and his group have been developing coarse-grained modeling methods on viruses such as HIV and influenza for more than 20 years. They 'coarsen' the data to make it simpler and more computationally tractable, while staying true to the dynamics of the system.

"The benefit of the coarse-grained model is that it can be hundreds to thousands of times more computationally efficient than the all-atom model," Voth explained. The computational savings allowed the team to build a much larger model of the coronavirus than ever before, at longer time-scales than what has been done with all-atom models.

"What you're left with are the much slower, collective motions. The effects of the higher frequency, all-atom motions are folded into those interactions if you do it well. That's the idea of systematic coarse-graining."

The holistic model developed by Voth started with atomic models of the four main structural elements of the SARS-CoV-2 virion: the spike, membrane, nucleocapsid, and envelope proteins. These atomic models were then simulated and simplified to generate the complete course-grained model.

The all-atom molecular dynamics simulations of the spike protein component of the virion system, about 1.7 million atoms, were generated by study co-author Rommie Amaro, a professor of chemistry and biochemistry at the University of California, San Diego.

"Their model basically ingests our data, and it can learn from the data that we have at these more detailed scales and then go beyond where we went," Amaro said. "This method that Voth has developed will allow us and others to simulate over the longer time scales that are needed to actually simulate the virus infecting a cell."

Amaro elaborated on the behavior observed from the coarse-grained simulations of the spike proteins.

"What he saw very clearly was the beginning of the dissociation of the S1 subunit of the spike. The whole top part of the spike peels off during fusion," Amaro said.

One of the first steps of viral fusion with the host cell is this dissociation, where it binds to the ACE2 receptor of the host cell.

"The larger S1 opening movements that they saw with this coarse-grained model was something we hadn't seen yet in the all-atom molecular dynamics, and in fact it would be very difficult for us to see," Amaro said. "It's a critical part of the function of this protein and the infection process with the host cell. That was an interesting finding."

Voth and his team used the all-atom dynamical information on the open and closed states of the spike protein generated by the Amaro Lab on the Frontera supercomputer, as well as other data. The National Science Foundation (NSF)-funded Frontera system is operated by the Texas Advanced Computing Center (TACC) at The University of Texas at Austin.

"Frontera has shown how important it is for these studies of the virus, at multiple scales. It was critical at the atomic level to understand the underlying dynamics of the spike with all of its atoms. There's still a lot to learn there. But now this information can be used a second time to develop new methods that allow us to go out longer and farther, like the coarse-graining method," Amaro said.

"Frontera has been especially useful in providing the molecular dynamics data at the atomistic level for feeding into this model. It's very valuable," Voth said.

The Voth Group initially used the Midway2 computing cluster at the University of Chicago Research Computing Center to develop the coarse-grained model.

The membrane and envelope protein all-atom simulations were generated on the Anton 2 system. Operated by the Pittsburgh Supercomputing Center (PSC) with support from National Institutes of Health, Anton 2 is a special-purpose supercomputer for molecular dynamics simulations developed and provided without cost by D. E. Shaw Research.

"Frontera and Anton 2 provided the key molecular level input data into this model," Voth said.

"A really fantastic thing about Frontera and these types of methods is that we can give people much more accurate views of how these viruses are moving and carrying about their work," Amaro said.

"There are parts of the virus that are invisible even to experiment," she continued. "And through these types of methods that we use on Frontera, we can give scientists the first and important views into what these systems really look like with all of their complexity and how they're interacting with antibodies or drugs or with parts of the host cell."

The type of information that Frontera is giving researchers helps to understand the basic mechanisms of viral infection. It is also useful for the design of safer and better medicines to treat the disease and to prevent it, Amaro added.

Said Voth: "One thing that we're concerned about right now are the UK and the South African SARS-CoV-2 variants. Presumably, with a computational platform like we have developed here, we can rapidly assess those variances, which are changes of the amino acids. We can hopefully rather quickly understand the changes these mutations cause to the virus and then hopefully help in the design of new modified vaccines going forward."

Credit: 
University of Texas at Austin, Texas Advanced Computing Center

Urban Americans more likely to follow covid-19 prevention behaviors than rural Americans

Timothy Callaghan, PhD, and Alva Ferdinand, DrPH, JD, from the Southwest Rural Health Research Center at Texas A&M University School of Public Health, joined colleagues in the first national study of how often people in urban and rural areas in the United States follow COVID-19 guidelines. These include public health best practices like wearing masks in public, sanitizing homes and work areas, maintaining physical distancing, working from home and avoiding dining in restaurants or bars.

The research team used a survey of 5,009 U.S. adults that closely matched the makeup of the country's population as a whole. The survey asked how often participants followed COVID-19 prevention recommendations and collected data on political ideology, perceived risk of getting COVID-19, whether participants had been tested for the disease, and how trusting of medical experts subjects were. They also collected data on demographic factors like age, gender, race, education, income and religiosity and used respondent ZIP code to determine whether they lived in a rural or urban area.

The research team found rural Americans were less likely than their urban counterparts to report following most of the recommended prevention behaviors. The two most notable differences were in wearing face coverings in public and in working from home. They also found smaller but significant differences in avoiding restaurants, changing travel plans and disinfecting homes and work areas, with rural residents again being less likely to follow recommendations. Other measures like social distancing, hand washing and canceling social engagements showed no significant differences between rural and urban-dwelling Americans.

When including political ideology and social factors in their analysis, the researchers found that some factors were associated with the likelihood of following recommendations. Older respondents and people who were more concerned about COVID-19 were more likely to follow at least some of the recommendations, as were those with greater educational attainment and higher income. People with a more conservative political ideology were less likely to follow prevention guidelines and women were more likely to follow them than men. However, living in a rural area remained a strong influence on following public health recommendations.

Given the limited access to high quality medical care in rural areas, these behaviors could lead to negative, yet avoidable, health outcomes in rural America. Finding ways to improve the adoption of COVID-19 prevention behaviors in rural areas is therefore critical, "something that targeted messaging might help to achieve," Callaghan said. "Public health efforts that consider factors like trust of medical experts and political ideology when reaching out to different groups could be key."

Credit: 
Texas A&M University

Diversity among study participants credited with identifying gene linked to asthma

image: L. Keoki Williams, M.D., MPH, the study's senior author and co-Director of Henry Ford Health System's Center for Individualized and Genomic Medicine Research.

Image: 
Henry Ford Health System

DETROIT (February 25, 2021) - Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including diverse patient populations in research studies.

The study is published in the print version of the American Journal of Respiratory and Critical Care Medicine.

For 14 years researchers have known that a casual variant for early onset asthma resides on chromosome 17, which holds one of the most highly replicated and significant genetic associations with asthma. Henry Ford researchers acknowledged they would not have identified it in this study without a diverse patient population that included African Americans, many from the metro Detroit area.

"This study is one of the best examples that demonstrates diversity matters in genetic research," said L. Keoki Williams, M.D., MPH, the study's senior author and co-Director of Henry Ford's Center for Individualized and Genomic Medicine Research. "African Americans have greater variation in their genome due to their African ancestry and this allowed us to pin-point a variant on chromosome 17 which has eluded asthma researchers for over a decade."

In an accompanying editorial written by researchers at the Harvard Medical School, the authors wrote that divergent genealogical histories can facilitate gene discovery. "In a time when our society is attempting to confront the ills of racial discrimination, including the ongoing racial disparities in healthcare, it is imperative that future studies are more inclusive to ensure that all peoples benefit equally in the post-genome era."

According to the National Center for Health Statistics, more than 41 million Americans had asthma in 2019, of which 18.5% were children less than 18 years of age. As a group, African Americans have some of the highest rates of asthma in the U.S. - 17.6% vs. 9.3% for African American children and non-Hispanic white children, respectively, and 15.2% vs. 13.8% for African American adults and non-Hispanic white adults, respectively.

The Henry Ford-led study was conducted in collaboration with researchers Esteban Burchard, M.D., MPH, at the University of California San Francisco (UCSF) and Hakon Hakonarson, M.D., Ph.D., at the Children's Hospital of Philadelphia (CHOP). It was part of the Asthma Translational Genomics Collaborative and the National Heart Lung and Blood Institute's Trans-Omics for Precision Medicine (TOPMed) program, a nationwide effort to use cutting-edge genetic technologies to better understand common, yet complex, diseases.

The study is believed to be the largest to date using whole genome sequencing for asthma research. It included 5,630 African American participants with and without asthma from the Henry Ford, UCSF and CHOP cohorts. Participants from Henry Ford were part of the Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity, or SAPPHIRE.

"African Americans have been represented in less than 3% of these types of studies, yet make up 13% of the U.S. population," said Hongsheng Gui, Ph.D., a Henry Ford researcher and study co-author. "Another reason to have diverse study populations is that many of the genetic risk markers found in one population group don't replicate in other population groups. However, the variant that we found appears to confer the same magnitude of asthma risk in both African Americans and non-Hispanic white Americans."

The variant that was identified resides in a gene called gasdermin-B, abbreviated GSDMB. Researchers found that the "protective" variant caused alternative splicing or editing of the final gene, resulting in a messenger RNA sequence missing exons 6 and 7. Researchers believe that this finding will help focus efforts to understand how this particular gene affects a child's risk of developing asthma.

Credit: 
Henry Ford Health

Development of an electroceutical to drastically reduce high-risk, preterm labor

image: 3D conceptual drawing for the ring-shaped electrode with stimulating, recording electrodes, and pre-amplifier

Image: 
Korea Institute of Science and Technology(KIST)

Preterm labor comprises 12.7% of all pregnancies. Although the overall rate of pregnancy is decreasing, the occurrence of premature birth due to preterm labor in south korea has been increasing over the past 7 years. Not only is preterm birth accountable for about a half of all neonatal mortality cases, the neurological deficits in surviving premature infants often lead to problems later in life, such as developmental disorders and respiratory complications. Currently, preterm labor is detected only when expecting mothers experience abnormal symptoms, or when they undergo a routine test like abdominal ultrasound or a laboratory test for vaginal secretions. It is difficult to detect preterm labor early, and there are few treatment options available other than pharmaceutical agents such as anti-contraction medications, with which side effects are of concern.

The Korea Institute of Science and Technology (KIST) announced that in collaboration with the research team led by Ki Hoon Ahn, Professor at the Department of OB/GYN, Korea University Anam Hospital and Dr. Soo Hyun Lee, the team at KIST Brain Science Institute (BSI) developed a non-invasive electroceutical for the early detection and simultaneous treatment of preterm labor.

While preterm labor is generally known to have various causes, including naturally occurring early contractions and premature rupture of membranes, a final symptom is irregular uterine contractions. The KIST research team developed a donut-shaped electrode that is inserted into the cervix to sense the signals of uterine contractions in real time, making the early diagnosis of preterm labor possible. Moreover, after sensing the signal of uterine contractions, the electrode can generate an electrical signal, thus functioning as an electroceutical to suppress uterine contractions by relaxing uterine muscles via sympathetic nerve stimulation.

The research team tested the safety and functioning of this electroceutical system for preterm labor detection and treatment using preterm-labor mouse and pig models, and confirmed that electrical stimulation generated from the system could delay and inhibit uterine contractions.

Professor Ki Hoon Ahn of Korea University Anam Hospital said, "Although new drug research and development (R&D) has been actively performed worldwide, the efficacy was not sufficient enough and there were side effects. We developed this system because there was a clinical need for a medical equipment with a novel mechanism." He also added that, "Infant mortality and the occurrence of sequelae due to preterm labor are expected to drastically decrease with the use of the first-ever medical device controlling uterine contractions."

Soo Hyun Lee, PhD, of KIST, contributed by saying that, "The donut-shaped electroceutical is not a therapy based on the existing pharmaceuticals, but a therapeutic tool to inhibit uterine contractions via electrical stimulation, and is likely to be developed further as a new concept-based medical technology." He added that, "The research was initiated as a project of the KIST-Korea University Anam Hospital Translation Research Center. In near future, we plan to conduct clinical research with government research grants, like an interagency program for medical device R&D."

Credit: 
National Research Council of Science & Technology

Sub-diffraction optical writing information bits: towards a high-capacity optical disk for Big Data

The total amount of data generated worldwide is expected to reach 175 ZB (Zettabytes; 1 ZB equals 1 billion Terabytes) by 2025. If 175 ZB were stored on Blu-ray disks, the disk stack would be 23 times the distance to the Moon. We face the urgent need to develop storage technologies that can accommodate this enormous amount of data.

The demand to store ever-increasing volumes of information has resulted in the widespread implementation of data centers for Big Data. These centers consume massive amounts of energy (about 3% of global electricity supply) and rely on magnetization-based hard disk drives with limited storage capacity (up to 2 TB per disk) and lifespan (up to 3-5 years). Laser-enabled optical data storage is a promising and cost-effective alternative for meeting this unprecedented demand. However, the diffractive nature of light has limited the size of the information bits that can be reached and, as a result, the storage capacity of the optical disks.

Researchers at USST, RMIT and NUS have now overcome this limitation by using earth-rich lanthanide-doped upconversion nanoparticles and graphene oxide flakes. This unique material platform enables low-power optical writing nanoscale information bits (nanoscale refers to sizes of 1-100 nanometers, where one nanometer is one billionth of a meter).

A much-improved data density can be achieved for an estimated storage capacity of 700 TB on a 12-cm optical disk, comparable to a storage capacity of 28,000 Blu-ray disks. Furthermore, the technology uses inexpensive continuous-wave lasers, reducing operating costs compared to traditional optical writing techniques using expensive and bulky pulsed lasers.

This technology also offers the potential for optical lithography of nanostructures in carbon based chips that are highly required in next-generation nanophotonic devices.

The impact

Optical data storage has advanced remarkably over the last decades, but the optical disk storage capacity is still limited to a few Terabytes.

The developed sub-diffraction optical writing technology can produce an optical disk with the largest storage capacity of all available optical devices.

While advances are needed to optimize the technology, the results open new avenues to address the global challenge of data storage. The technology is suited to the mass production of optical disks, so that the potential is enormous.

This ground-breaking technology could offer a cheaper and sustainable solution for the next generation of high-capacity optical data storage while enabling the energy-efficient nanofabrication of flexible graphene based electronics.

Credit: 
University of Shanghai for Science and Technology

On the line: Watching nanoparticles get in shape

video: Imaging of the same spot shows that cracks eventually self-heal, an important trademark that maintains the integrity of structured liquids. Real-time video of 70 nm nanoparticles (red) and 500 nanometer nanoparticles (green) captured via laser scanning confocal microscopy at the Molecular Foundry.

Image: 
Paul Ashby and Tom Russell/Berkeley Lab and Science Advances

Liquid structures - liquid droplets that maintain a specific shape - are useful for a variety of applications, from food processing to cosmetics, medicine, and even petroleum extraction, but researchers have yet to tap into these exciting new materials' full potential because not much is known about how they form.

Now, a research team led by Berkeley Lab has captured real-time high-resolution videos of liquid structures taking shape as nanoparticle surfactants (NPSs) - soap-like particles just billionths of a meter in size - jam tightly together, side by side, to form a solid-like layer at the interface between oil and water.

Their findings, recently featured on the cover of Science Advances , could help researchers better optimize liquid structures to advance new biomedical applications such as reconfigurable microfluidics for drug discovery and all-liquid robotics for targeted cancer drug delivery, among others.

In experiments led by co-author Paul Ashby , a staff scientist in Berkeley Lab's Molecular Foundry and Materials Sciences Division, and Yu Chai, a former postdoctoral researcher in the Ashby group who is now an assistant professor at The City University of Hong Kong, the researchers used a special imaging technique called atomic force microscopy (AFM) to take the first-ever real-time movies of the NPSs crowding together and getting jammed at the oil-water interface, a critical step in locking a liquid into a specific shape.

The researchers' movies unveiled a portrait of the NPS interface with unprecedented detail, including the size of each NPS, whether the interface was composed of one or multiple layers, and how much time elapsed, down to the second, for each NPS to attach to and settle into the interface.

The spectacular AFM images also showed the angle at which an NPS "sits" at the interface - an unexpected result. "We were surprised by how rough the interfaces are," Ashby said. "We had always drawn illustrations of a uniform interface with nanoparticles attached at the same contact angle - but in our current study, we found there is actually a lot of variation."

Most nanoscale imaging tools can only investigate immobile samples that are either dry or frozen. Over the past couple of decades, Ashby has focused his research on developing unique AFM capabilities that allow the user to control the probe tip so it gently interacts with fast-moving samples, such as the NPSs of the current study, without touching the underlying liquid - a challenging feat.

"Imaging a liquid structure at the nanoscale, and watching the nanoparticles move around in liquid in real time using an AFM probe - that wouldn't be possible without Paul's extensive expertise," said co-author Thomas Russell , a visiting faculty scientist and professor of polymer science and engineering from the University of Massachusetts who leads the Adaptive Interfacial Assemblies Towards Structuring Liquids program in Berkeley Lab's Materials Sciences Division. "These kinds of capabilities aren't available anywhere else except at the Molecular Foundry."

The researchers next plan to study the effect of self-propelling particles in NPS liquid structures.

Credit: 
DOE/Lawrence Berkeley National Laboratory

A-maze-ing pheasants have two ways of navigating

image: A maze used in the study (here with all doors/walls open).

Image: 
Pip Laker

Pheasants fall into two groups in terms of how they find their way around - and the different types prefer slightly different habitats, new research shows.

University of Exeter scientists tested whether individual pheasants used landmarks (allocentric) or their own position (egocentric) to learn the way through a maze.

The captive-bred pheasants were later released into the wild, and their choice of habitat was observed.

All pheasants favoured woodland, but allocentric navigators spent more time out in the open, where their landmark-based style is more useful.

"Humans tend to use both of these navigational tactics and quite frequently combine them, but when animals are tested, they often seem to rely more on one or the other," said Dr Christine Beardsworth.

"It is assumed that species favour whichever strategy suits their habitat, rather than using habitats which suit their strategy.

"Pheasants generally favour woodland, where an allocentric strategy is difficult because there are lots of trees close together, so it is hard to pick out landmarks.

"So, we might expect most pheasants to use an egocentric strategy - turning left, turning right or moving forward based on their own position and previous movements.

"However, in our study about half of pheasants reared in identical conditions used an allocentric strategy, while the other half used an egocentric or mixed strategy."

In the experiments, 20 pheasants first learned how to navigate through a simple maze, then faced a rotated version.

By altering the orientation of the maze but keeping the placement of "landmarks" the same, including the position of a human observer, the scientists were able to establish the preferred navigation strategy of each pheasant.

The discovery of individual variation suggest pheasants are either born with an "inherent cognitive bias", or develop one early in life.

Resulting differences in habitat selection may indicate that these biases help them to navigate more effectively in particular environments, perhaps outperforming other pheasants in relocating resources. However, it is not yet clear whether this is the case.

Credit: 
University of Exeter

Politicized pandemic shaped compliance with social distancing

COLUMBUS, Ohio - Politicization of the COVID-19 pandemic had a powerful influence over adherence to social distancing guidelines in the United States and why people did, or did not, comply during the lockdown days, a new study has found.

The analysis boiled down to whom study participants trusted most: scientists or President Donald Trump.

"People who expressed a great deal of faith in President Trump, who thought he was doing an effective job of guiding us through the pandemic, were less likely to socially distance," said Russell Fazio, senior author of the study and a professor of psychology at The Ohio State University. "In contrast, the people who expressed a great deal of trust in scientists showed the exact opposite pattern: They were more likely to engage in social distancing.

"We were getting two-sided messages at the time from our government officials and public health scientists, so we had these two sources that were, in effect, working in opposition to one another. That pointed to the politicization of the pandemic."

The study is published today (Feb. 24, 2021) in PLOS ONE.

Fazio's lab studies how personal beliefs and attitudes influence behavior. When COVID-19's emergence in the United States led to lockdowns and stay-at-home orders, the national directive to socially distance became an enormous science experiment.

"On the basis of everything we've known for decades of social psychology, it seemed clear that people's pre-existing beliefs would affect their interpretations of the seriousness of the pandemic and the extent to which they would comply with these recommendations," Fazio said. "We thought we needed to directly assess that empirically, find out who was indeed complying or not complying, and get some idea about which beliefs mattered."

According to the authors' theoretical framework, three components were at play when the information campaign began: the source of the message, what kind of challenge the context presented - is the virus really a threat? - and the self-views of the targets, in this case the entire U.S. population.

The researchers recruited participants from Amazon's Mechanical Turk crowdsourcing marketplace. The sample in this study consisted of 2,001 U.S. adults representing a range of ages, geographical locations and political ideologies.

The team surveyed the participants in early May about their personal beliefs on a range of issues associated with the pandemic: how much they trusted the sources of information, the extent of their worry about the dangers of the virus, and how concerned they were for others' vulnerability to getting sick. Did they believe in the value of science, trust the federal government's handling of the pandemic, weigh economic concerns over public health, consider themselves compassionate?

"We were interested in the extent to which an individual had a self-view as a compassionate person, because at least part of the reason we were all engaging in social distancing was to protect one another. We were also interested, because of all of the misinformation that was floating around, in people's general tendency toward conspiratorial thinking," Fazio said.

Questions about beliefs and political leanings were combined with a knowledge check: a true-or-false quiz on 13 facts and myths about the coronavirus.

To gauge participants' social distancing behavior, the researchers presented study participants with 10 virtual behavior scenarios of various public settings - a grocery store, a crowded beach, a crosswalk - and asked them to place themselves or fictional people in those contexts based on their social distancing preferences. Though the researchers also asked participants to self-report their social distancing practices, the virtual scenarios requiring "in the moment" decisions about reactions to different situations were considered more representative of how people actually behaved in real life.

In fact, a recently published study involving follow-up data showed that the more participants demonstrated a preference for social distancing in the virtual scenarios, the less likely they were to have gotten sick with COVID-19 in the subsequent four months - a finding that established the validity of the virtual measures.

Statistical analyses revealed several correlations. Trust in scientists, support for the guidelines, belief that the virus threat was not exaggerated, concern about its spread, general science literacy and COVID-19 knowledge were strongly associated with the practice of social distancing. Trust and confidence in President Trump and the federal government's effectiveness, belief in conspiracy theories, a political lean toward conservatism and an opinion that economic health was more important than safety were linked to lower odds of practicing social distancing.

Fazio said the findings may make one wonder what might have been had the U.S. populace been exposed to more consistent messaging.

"If there had been a single coherent voice communicating information, leading people to understand how serious the threat was and encouraging all of these preventive behaviors, including social distancing, I think we would have seen far more compliance," he said. "That is what comes through the data very clearly."

Credit: 
Ohio State University

Materials scientists show way to make durable artificial tendons from improved hydrogels

video: Stretch testing of an artificial tendon material developed by UCLA materials scientists. The width of the test material is about 2 mm.

Image: 
Mutian Hua, Shuwang Wu, and Ximin He/UCLA

UCLA materials scientists and their colleagues have developed a new method to make synthetic biomaterials that mimic the internal structure, stretchiness, strength and durability of tendons and other biological tissues.

The researchers developed a two-pronged process to enhance the strength of existing hydrogels that could be used to create artificial tendons, ligaments, cartilage that are 10 times tougher than the natural tissues. Although the hydrogels contain mostly water with little solid content (about 10% polymer), they are more durable than Kevlar and rubber, which are both 100% polymer. This kind of breakthrough has never been achieved in water-laden polymers until this study, which was recently published in Nature. The new hydrogels could also provide coating for implanted or wearable medical devices to improve their fit, comfort and long-term performance.

"This work shows a very promising pathway toward artificial biomaterials that are on par with, if not stronger than, natural biological tissues," said study leader Ximin He, an assistant professor of materials science and engineering at the UCLA Samueli School of Engineering.

Hydrogels are a broad class of materials with interior structures made up of crisscrossing polymers or gels. They show promise for use as replacement tissues, either to temporarily close wounds or as a long-term or even permanent solution. In addition, the gels may have applications for soft robots and wearable electronics.

However, current hydrogels are not strong or durable enough to mimic or replace tissues that need to move and flex repeatedly while bearing weight. To address these issues, the UCLA-led team employed a combination of molecular and structural engineering approaches that were not previously utilized together to make hydrogels.

First, the researchers used a method called "freeze-casting" -- a solidifying process that results in porous and concentrated polymers, similar to a sponge. Second, they used a "salting-out" treatment to aggregate and crystalize polymer chains into strong fibrils. The resulting new hydrogels have a series of connecting structures across several different scales -- from molecular levels up to a few millimeters. The hierarchy of these multiple structures, similar to that of biological counterparts, enables the material to be stronger and more stretchable.

As demonstrated by the team, this versatile method is highly customizable and could replicate various soft tissues in the human body.

The researchers used polyvinyl alcohol, a material already approved by the U.S. Food and Drug Administration, to make their hydrogel prototype. They tested its durability, seeing no signs of deterioration after 30,000 cycles of stretch testing. Under light, the new hydrogel produced a vivid shimmer, similar to real tendons, confirming the micro/nano structures that formed in the gel.

In additional to biomedical applications, the advance may hold potential for surgical machines or bioelectronics that operate innumerable cycles, and 3D printing of previously unachievable configuration, thanks to the hydrogel's flexibility. In fact, the team demonstrated that such 3D-printed hydrogel architectures could transform into other shapes pending changes in temperature, acidity or humidity. Acting as artificial muscles, they are much more resilient and could exert great force.

Credit: 
University of California - Los Angeles

Subcutaneous semaglutide vs. placebo as adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity

What The Study Did: This randomized clinical trial compares the effects of once-weekly subcutaneous semaglutide versussplacebo for weight management as an adjunct to intensive behavioral therapy with initial low-calorie diet in adults with overweight or obesity.

Authors: Thomas A. Wadden, Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.1831)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

Efficient, systematic genetic analysis helps dissect disease inheritance

image: An overview of the SNP-SELEX experimental procedure developed by the collaborative team.

Image: 
DOI: 10.1038/s41586-021-03211-0

Many genetic variants have been found to have a linkage with genetic diseases, but the understanding of their functional roles in causing diseases are still limited. An international research team, including a biomedical scientist from City University of Hong Kong (CityU), has developed a high-throughput biological assay technique which enabled them to conduct a systematic analysis on the impact of nearly 100,000 genetic variants on the binding of transcription factors to DNA. Their findings provided valuable data for finding key biomarkers of type 2 diabetes for diagnostics and treatments. And they believe that the new technique can be applied to studies of variants associated with other genetic diseases.

The study was co-led by Dr Yan Jian, Assistant Professor in the Department of Biomedical Sciences at CityU, Professor Bing Ren from the University of California San Diego and Professor Jussi Taipale from the University of Cambridge. Their findings were published in the prestigious scientific journal Nature, titled "Systematic analysis of binding of transcription factors to noncoding variants".

"Based on our findings, we believe that our high-throughput experimental method can be applied in the study of different genetic diseases, including colorectal cancer and prostate cancer. It can help dissect the mechanism of the genetic inheritance of the disease and find the biomarkers for clinical diagnosis," said Dr Yan.

Unveiling the roles of noncoding variants in diseases

Genome-wide association studies (GWAS), which investigate the entire genome, has been the most important strategy in finding the genes associated with complex genetic diseases. Researchers have found hundreds of thousands of genetic variants in association with human diseases and traits. But studies on the functions of these variants are still limited.

"Understanding the molecular functions of the noncoding variants will help us find out why people carrying these mutations are more susceptible to genetic diseases. This will help us develop methods or strategies to prevent, to detect or to cure the diseases early," explained Dr Yan.

One of the variants' functions is to affect the binding of transcription factors to DNA. The transcription factors will then control the gene expression in cells, turning the specific genes "on" and "off", modulating the cellular functions.

To systematically characterise the effects of genetic variants on the transcription factor binding, the team modified their previously developed experimental method into an ultra-high-throughput multiplex protein-DNA binding assay, termed "single-nucleotide polymorphism evaluation by systematic evolution of ligands by exponential enrichment" (SNP-SELEX). Then they chose the genetic variants from the gene locations on the genome (called "gene loci") that are known to be associated with the risk of type 2 diabetes as the object of analysis.

Utilising the SNP-SELEX, they successfully analysed the impact of 95,886 genetic variants on the binding of 270 distinct human transcription factors to DNA. They demonstrated that noncoding genetic variant SNP rs7118999 that increases the risk of type 2 diabetes can affect the DNA binding with one of the transcription factors, and the resulting molecular mechanism regulates the blood lipid level.

"This is a clear example of applying the data generated by SNP-SELEX that it can help identify the genetic variants which play key roles in the inheritance of type 2 diabetes. This would help the subsequent investigation in finding diagnostic biomarkers and therapeutic targets," said Dr Yan.

Speeding Up Analysis Significantly

Moreover, previous studies could only single out one or a few variants to find out its molecular mechanism. Each study took around 2-3 years. "So it was impossible to completely understand the complex genetic diseases like type 2 diabetes which are associated with hundreds of genetic variants within a short period. But with the SNP-SELEX, we could systematically analyse approximately 100,000 variants within a much shorter timeframe," said Dr Yan.

"In this study, we only covered a relatively small portion of variants and transcription factors. So we will expand our study. By utilising the SNP-SELEX, hopefully it will help us uncover the underlying mechanisms of more and more of these noncoding variants very soon," said Professor Ren.

Credit: 
City University of Hong Kong

Story tips from Johns Hopkins experts on Covid-19

RESEARCHERS MAY HAVE UNCLOUDED THE MYSTERY OF COVID-19 'BRAIN FOG'

Media Contact: Michael E. Newman, mnewma25@jhmi.edu

People who survive a severe case of COVID-19 have reported a variety of lingering aftereffects, but perhaps none as unusual as what has been popularly called "brain fog." Clinically known as dysexecutive syndrome, the condition is a COVID-19-kindled delirium, initially experienced by patients -- mostly older -- while sick as a state of confusion and impaired awareness. It then often stays on after recovery to torment as persistent cognitive sluggishness. Unfortunately, the origin of brain fog has remained unclear.

Now, pathologists at Johns Hopkins Medicine in Baltimore and Brigham and Women's Hospital in Boston have found evidence that large bone marrow cells known as megakaryocytes may be responsible for the brain fog. They suggest that megakaryocytes migrate to the brain in a journey precipitated by the destructive activity of SARS-CoV-2, the virus that causes COVID-19.

There, the researchers believe, the out-of-place cells may reduce or completely block the flow of nourishing blood through individual capillaries in the cerebral cortex -- the area of the brain where most information processing occurs. Such capillary occlusions, they say, could lead to neurological impairment.

The team's findings are reported in a research letter published Feb. 12 in JAMA Neurology.

Megakaryocytes are the cells responsible for production of platelets --blood components that are necessary for clotting and wound repair.

Interestingly, the researchers say, a scientific literature search they conducted indicates this may be the first time that megakaryocytes have been found in blood vessels in the human brain.

The researchers evaluated brain tissue from autopsies of 15 patients who died of COVID-19. In five of the samples, they discovered large cell nuclei resembling those of megakaryocytes in the cortical capillaries. Immunohistochemical testing confirmed that the nuclei were those of megakaryocyte immigrants from bone marrow.

No megakaryocyte nuclei were found in post-mortem brain tissues from decedents who were negative for the COVID-19 coronavirus and served as the study's control group.

What isn't clear is how the COVID-19-associated megakaryocytes are signaled to leave the bone marrow or how they can navigate the fine network of lung blood vessels on their way to the brain, says David Nauen, M.D., Ph.D., study lead author and assistant professor of pathology at the Johns Hopkins University School of Medicine.

"We suspect that SARS-CoV-2 damages lung tissue, leading to the release of chemical signals that induce the megakaryocytes to travel there from the bone marrow," says Nauen. "When that happens, these large cells somehow find a way to pass through the lung capillaries and get to the brain."

"We don't yet know if the megakaryocytes we found in the brain are just the result of blood flow carrying them there or if a specific change occurs in the brain vessels that trap them," he adds.

Nauen says the researchers plan next to characterize what happens in the brain tissue and cortical capillaries during severe cases of COVID-19 to better understand how megakaryocytes are signaled and recruited.

"Because standard brain autopsy sections represent only a minute portion of the cerebral cortex, the actual numbers of these cells in the brain as a result of COVID-19 could be considerable -- as could their potentially negative neurological impacts on those who survive," says Nauen.

Nauen is available for comment about these research findings.

SCIENTISTS ARE BUILDING MORE COMPREHENSIVE TESTS FOR COVID-19

Media Contact: Vanessa Wasta, wasta@jhmi.edu

New strains of SARS-CoV-2, the virus that causes COVID-19, may have greater transmissibility or altered virulence, or may exhibit resistance to the current vaccines. Now, scientists are racing to develop better ways to detect emerging SARS-CoV-2 strains among the high number of diagnosed infections.

Johns Hopkins assistant professor of pathology Ben Larman, Ph.D., and his team have been working to improve the analysis of genetic material called RNA that forms the genome of many viruses.

Specifically, the Johns Hopkins team is developing a technique to scan biological specimens, including saliva or specimens obtained with nasal swabs, using specialized DNA probes that sift through a complex "forest" of RNA sequences. The probes can detect specific RNA sequences of viruses and other disease-causing pathogens.

A report describing the development and application of the test (cRASL-seq), led by Larman and postdoctoral fellow Joel Credle, Ph.D., appeared online Feb. 3 in the journal Modern Pathology.

A key feature of the newly developed test, says Larman, is its ability to analyze and detect the many subtle changes that can occur in the SARS-CoV-2 viral genome -- so-called variants, such as those first identified in the United Kingdom and South Africa.

Read more about development of the test.

Larman is available for interviews.

Credit: 
Johns Hopkins Medicine

Semaglutide paired with intensive behavioral therapy showed triple weight loss vs placebo

PHILADELPHIA -- A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40 percent of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published today in the Journal of the American Medical Association.

The 68-week study was conducted at 41 sites in the United States from August 2018 to April 2020 and was designed to boost total weight loss with semaglutide by combining the medication with a more intensive diet and physical activity program than what was used in the STEP 1 trial, published online February 10th in the New England Journal of Medicine. All participants in the new STEP 3 study received 30 sessions of intensive behavioral therapy consisting of diet and physical activity counseling, which was combined with an initial 8-week, 1000-1200 kcal/day meal-replacement diet, consisting of shakes, meal bars, and prepared entrees.

"We wanted to induce a large weight loss with rigorous behavioral therapy and see how much additional weight loss semaglutide could add," said lead author Thomas Wadden, PHD, a professor of psychology in the Department of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania.

The 611 participants in the STEP 3 trial had an average starting weight of 233 pounds with a body mass index of 38 kg/m2. The participants taking semaglutide were given a 2.4 mg dose once weekly. After 68 weeks of treatment, the semaglutide group lost an average of 16 percent of baseline body weight, equal to 37 pounds, compared with 5.7 percent, 14 pounds for those assigned to intensive behavioral therapy combined with placebo. Substantially greater proportions of semaglutide-treated participants (75 percent), compared with placebo (27 percent), achieved weight losses of 10 percent or more of baseline weight.

"These are remarkable weight losses, particularly the one third of participants who lost 20 percent of baseline weight, a reduction that approaches that achieved with sleeve gastrectomy, a widely used bariatric surgery procedure," Wadden said. "Further study is needed to determine if patients can sustain these substantial losses with long-term use of semaglutide 2.4 mg."

The larger weight losses achieved with semaglutide than with placebo were associated with greater improvements in cardiometabolic risk factors, including changes in waist circumference, systolic blood pressure, hemoglobin A1c, and triglycerides.

"These metabolic benefits and marked improvements in risk factors hold great promise for the prevention and treatment of diabetes and cardiovascular disease," said W. Timothy Garvey, MD, a study co-author and professor of medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham. "The unprecedented degree of weight loss is also sufficient to prevent and treat other complications of obesity including osteoarthritis, sleep apnea, and non-alcoholic fatty liver disease," he added.

Gastrointestinal side effects were reported by 83 percent of semaglutide participants and included mild-to-moderate nausea and diarrhea that generally improved over time, without the need to discontinue the drug.

Semaglutide is a glucagon-like-peptide 1 (GLP-1) receptor agonist which, at a dose of 1.0 mg once weekly, is approved (as Ozempic) by the U.S. Food and Drug Administration for the management of type 2 diabetes. The higher dose of 2.4 mg, currently being evaluated by the FDA for chronic weight management, appears to affect appetite centers in the brain that control hunger and cravings, leading to a reduction in food and calorie intake. Patients also report feeling full more quickly when eating. The medication is taken once weekly by self-injection under the skin.

"The results with semaglutide appear to be the breakthrough in weight management that health care providers and their patients with obesity have been waiting for," said Wadden. "It's clear that adding semaglutide to intensive behavioral therapy could substantially increase the proportions of patients who lose 10 percent or more of their starting weight, with accompanying improvements in health and mobility."

A question left unanswered by the present study is how much lifestyle counseling is needed with semaglutide to lose an average of approximately 15 percent of baseline weight. Semaglutide-treated participants in the STEP 1 trial lost 14.9 percent of starting weight, with 18 sessions of lifestyle counseling, compared with 2.4 percent for placebo.

"For the placebo-treated participants in STEP 3, the 30 intensive behavioral therapy sessions and meal-replacement diet appeared to increase weight loss by approximately 3 percentage points, as compared with the less intensive lifestyle counseling provided in the STEP 1 trial," Wadden noted. "However, a comparable benefit was not observed in combining rigorous behavioral treatment with semaglutide, suggesting that further study is needed of the optimal program of lifestyle counseling required with semaglutide at the higher dose currently being evaluated."

Credit: 
University of Pennsylvania School of Medicine